Hit validation is a critical step that ensures screening «hits» are genuine and not false positives caused by assay interference. Our goal is to confirm that the identified hits are specific and have the potential to evolve into viable drug candidates.
Early assessment of drug-like properties —including solubility, stability, and pharmacokinetic profile— facilitates the prioritization of viable candidates. Without proper validation, resources may be wasted optimizing inactive or nonspecific compounds. By validating hits, our scientific team will reduce the risk of late-stage failures in your drug pipeline.
Ultimately, our Hit validation service provides the scientific confidence needed to progress toward lead identification with reduced risk and greater efficiency, helping accelerate the development of innovative therapeutic compounds.
